| Reporting Segment | Product Linearrow_drop_up | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biopharma Laboratory Services (BLS) |
Contract Clinical Testing Services for Drug Manufacturers
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
|
2.77B | 22.76% |
| Labcorp Diagnostics (Dx) |
Diversified Medical Diagnostic Services; Government Insurance
These companies operate diversified diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
1B | 8.19% |
| Labcorp Diagnostics (Dx) |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| Labcorp Diagnostics (Dx) |
Medical Diagnostic Services; Private Insurance
These companies operate diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
8.42B | 69.05% |
| keyboard_arrow_down |
Biopharma Laboratory Services (BLS)
Contract Clinical Testing Services for Drug Manufacturers
|
2.77B | 22.76% |
| keyboard_arrow_right |
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
|
||
| keyboard_arrow_down |
Labcorp Diagnostics (Dx)
Diversified Medical Diagnostic Services; Government Insurance
|
1B | 8.19% |
| keyboard_arrow_right |
These companies operate diversified diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
||
| keyboard_arrow_down |
Labcorp Diagnostics (Dx)
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
||
| keyboard_arrow_down |
Labcorp Diagnostics (Dx)
Medical Diagnostic Services; Private Insurance
|
8.42B | 69.05% |
| keyboard_arrow_right |
These companies operate diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||